Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial
Titel:
Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial
Auteur:
Henderson, Michael A Burmeister, Bryan H Ainslie, Jill Fisher, Richard Di Iulio, Juliana Smithers, B Mark Hong, Angela Shannon, Kerwin Scolyer, Richard A Carruthers, Scott Coventry, Brendon J Babington, Scott Duprat, Joao Hoekstra, Harald J Thompson, John F